HighTower Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

HighTower Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-15,100	Closed	-$249K	–	3496
2021 Q1	$249K	Buy	15,100 +500	+3%	+$11.4K	﹤0.01%	2433
2020 Q4	$269K	Buy	+14,600	New	+$261K	﹤0.01%	2009
2020 Q2	–	Sell	-13,349	Closed	-$133K	–	2574
2020 Q1	$133K	Buy	+13,349	New	+$109K	﹤0.01%	1900

Other funds holding TBIO

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AVA

Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HighTower Advisors's TBIO Position: Q2 2021 in Review

HighTower Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 15,100 shares — an estimated $249K sold.

HighTower Advisors first reported a position in TBIO in Q1 2020 and held it in 3 quarters. The position peaked at $269K in Q4 2020. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

HighTower Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
HighTower Advisors sold 15,100 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $249K.
HighTower Advisors first reported a position in Translate Bio, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
HighTower Advisors's Translate Bio, Inc. Common Stock position peaked at $269K in Q4 2020.
145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on HighTower Advisors's 13F filing for Q2 2021, filed 6 Aug 2021.